Sagasrin-A
Description_Effects
Sagasrin-A is a combination medication that contains Aceclofenac and Diacerein, specifically formulated to relieve symptoms associated with joint and muscle disorders, such as osteoarthritis and rheumatoid arthritis. This dual-action formulation provides both anti-inflammatory and cartilage-protective benefits, offering comprehensive support for joint health. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking the production of prostaglandins, substances in the body responsible for causing pain, swelling, and inflammation. By inhibiting these chemicals, Aceclofenac effectively reduces pain, redness, and swelling in affected joints and muscles, improving mobility and overall comfort. Diacerein, on the other hand, is a disease-modifying osteoarthritis drug (DMOAD) known for its cartilage-protective properties. It works by inhibiting interleukin-1 (IL-1), a pro-inflammatory cytokine that contributes to cartilage degradation. Diacerein also stimulates the synthesis of proteoglycans, essential components of healthy cartilage, helping to slow down the progression of degenerative joint conditions and support long-term joint repair. Together, Sagasrin-A not only alleviates pain and inflammation but also promotes cartilage regeneration and delays structural damage in the joints. It is typically prescribed for patients suffering from chronic joint conditions and should be used under medical supervision for optimal results and safety.
